Stenger Family Office’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.1M Buy
6,754
+379
+6% +$387K 1.29% 23
2026
Q1
$5.86M Buy
6,375
+595
+10% +$603K 1.04% 26
2025
Q4
$6.21M Buy
5,780
+2,144
+59% +$2.05M 1.28% 20
2025
Q3
$3M Buy
3,636
+649
+22% +$483K 0.62% 45
2025
Q2
$2.27M Buy
+2,987
New +$2.32M 0.58% 50

Other funds holding LLY

Stenger Family Office's LLY Position: Q2 2026 in Review

Stenger Family Office increased its Eli Lilly (LLY) stake by 5.9% in Q2 2026, buying an estimated $387K and bringing the position to 6,754 shares worth $8.1M. The position accounts for 1.29% of the portfolio, ranked #23.

Stenger Family Office first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 1,573 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Stenger Family Office held 6,754 shares of Eli Lilly worth $8.1M as of Q2 2026.
  • Stenger Family Office bought 379 Eli Lilly shares in Q2 2026, an estimated $387K.
  • Eli Lilly made up 1.29% of Stenger Family Office's portfolio in Q2 2026, its #23 holding.
  • Stenger Family Office first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 1,573 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Stenger Family Office's 13F filing for Q2 2026, filed 13 Jul 2026.